Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness

11 min read Original article ↗

Abstract

In a large-scale (N = 1487) general population online study, we investigated the relationship between past experience with classic psychedelic substances (e.g. LSD, psilocybin, mescaline), nature relatedness, and ecological behavior (e.g. saving water, recycling). Using structural equation modeling we found that experience with classic psychedelics uniquely predicted self-reported engagement in pro-environmental behaviors, and that this relationship was statistically explained by people’s degree of self-identification with nature. Our model controlled for experiences with other classes of psychoactive substances (cannabis, dissociatives, empathogens, popular legal drugs) as well as common personality traits that usually predict drug consumption and/or nature relatedness (openness to experience, conscientiousness, conservatism). Although correlational in nature, results suggest that lifetime experience with psychedelics in particular may indeed contribute to people’s pro-environmental behavior by changing their self-construal in terms of an incorporation of the natural world, regardless of core personality traits or general propensity to consume mind-altering substances. Thereby, the present research adds to the contemporary literature on the beneficial effects of psychedelic substance use on mental wellbeing, hinting at a novel area for future research investigating their potentially positive effects on a societal level. Limitations of the present research and future directions are discussed.

Get full access to this article

View all access and purchase options for this article.

References

Aron A, Aron EN, Tudor M, et al. (1991) Close relationships as including other in the self. J Pers Soc Psychol 60: 241–253.

Atran S, Medin D, Ross N, et al. (2002) Folkecology, cultural epidemiology, and the spirit of the commons: A garden experiment in the Maya lowlands, 1991–2001. Curr Anthropol 43: 421–450.

Bachman JG, O’Malley PM, Johnston LD (1980) Correlates of Drug Use, Part I: Selected Measures of Background, Recent Experiences, and Life-style Orientations. Ann Arbor, MI: Institute for Social Research.

Ball SA (2005) Personality traits, problems, and disorders: Clinical applications to substance use disorders. J Res Pers 39: 84–102.

Berenguer J (2007) The effect of empathy in proenvironmental attitudes and behaviors. Environ Behav 39: 269–283.

Bogenschutz MP, Pommy JM (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: From indirect evidence to testable hypotheses. Drug Test Anal 4: 7–8.

Bogg T, Roberts BW (2004) Conscientiousness and health-related behaviors: A meta-analysis of the leading behavioral contributors to mortality. Psychol Bull 130: 887–919.

Boumba VA, Mitselou A, Vougiouklakis T (2004) Fatal poisoning from ingestion of Datura stramonium seeds. Vet Hum Toxicol 46: 81–82.

Brown TK (2013) Ibogaine in the treatment of substance dependence. Curr Drug Abuse Rev 6: 3–16.

Bratman GN, Hamilton JP, Hahn KS, et al. (2015) Nature experience reduces rumination and subgenual prefrontal cortex activation. Proc Natl Acad Sci USA 112: 8567–8572.

Boynton MH, Richman LS (2014) An online daily diary study of alcohol use using Amazon’s Mechanical Turk. Drug Alcohol Rev 33: 456–461.

Buhrmester M, Kwang T, Gosling SD (2011) Amazon’s Mechanical Turk a new source of inexpensive, yet high-quality, data? Perspect Psychol Sci 6: 3–5.

Capaldi CA, Dopko RL, Zelenski JM (2014) The relationship between nature connectedness and happiness: A meta-analysis. Front Psychol 5: 976.

Carbonaro TM, Bradstreet MP, Barrett FS, et al. (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 30: 1268–1278.

Carhart-Harris RL, Bolstridge M, Rucker J, et al. (2016) Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. Lancet Psychiatry 3: 619–627.

Carhart-Harris RL, Erritzoe D, Williams T, et al. (2012a) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci USA 109: 2138–2143.

Carhart-Harris RL, Leech R, Williams TM, et al. (2012b) Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin. Br J Psychiatry 200: 238–244.

Carhart-Harris RL, Kaelen M, Whalley MG, et al. (2015) LSD enhances suggestibility in healthy volunteers. Psychopharmacology 232: 785–794.

Corazza O, Schifano F, Simonato P, et al. (2012) Phenomenon of new drugs on the Internet: The case of ketamine derivative methoxetamine. Hum Psychopharm Clin 27: 145–149.

Courtwright DT (2001) Forces of Habit: Drugs and the Making of the Modern World. Cambridge, MA: Harvard University Press.

Curran HV, Morgan C (2000) Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95: 575–590.

DEFRA (2008) A Framework for Pro-environmental Behaviours. London, UK: Department for Environment, Food and Rural Affairs.

Dumont GJ, Sweep FC, van der Stehen R, et al. (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci 4: 359–366.

Feinberg M, Willer R (2013) The moral roots of environmental attitudes. Psychol Sci 24: 56–62.

Galinsky AD, Ku G, Wang CS (2005) Perspective-taking and self-other overlap: Fostering social bonds and facilitating social coordination. Group Process Intergroup Relat 8: 109–124.

Gasser P, Holstein D, Michel Y, et al. (2014) Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 202: 513–520.

Gebhard U, Nevers P, Billmann-Mahecha E (2003) Moralizing trees: Anthropomorphism and identity in children’s relationships to nature. In: Clayton S (ed.) Identity and the Natural Environment: The Psychological Significance of Nature. Cambridge, UK: MIT Press, pp. 45–66.

Goodman JK, Cryder CE, Cheema A (2013) Data collection in a flat world: The strengths and weaknesses of Mechanical Turk samples. J Behav Decis Mak 26: 213–224.

Gosling SD, Rentfrow PJ, Swann WB Jr (2003) A very brief measure of the Big-Five personlity domains. J Res Pers 37: 504–528.

Gray K, Young L, Waytz A (2012) Mind perception is the essence of morality. Psychol Inq 23: 101–124.

Griffiths RR, Richards W, Johnson M, et al. (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol 22: 621–632.

Griffiths RR, Johnson MW, Richards WA, et al. (2011) Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology 218: 649–665.

Griffiths RR, Richards WA, McCann U, et al. (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187: 268–283.

Hendricks PS, Thorne CB, Clark CB, et al. (2015) Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol 29: 280–288.

Hollister L (1984) Effects of hallucinogens in humans. In: Jacobs B (ed.) Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives. New York, NY: Raven Press, pp. 203–226.

Hussong AM (2000) The settings of adolescent alcohol and drug use. J Youth Adolesc 29: 107–119.

IPCC (2014) Climate Change 2014: Synthesis Report. Contribution of Working Groups I, II and III to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Geneva, Switzerland: IPCC.

Johansen P-Ø, Krebs TS (2015) Psychedelics not linked to mental health problems or suicidal behavior: A population study. J Psychopharmacol 29: 270–279.

Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: Guidelines for safety. J Psychopharmacol 22: 603–620.

Kellert SR, Wilson EO (1995) The Biophilia Hypothesis. Washington, DC: Island Press.

Kesebir S, Kesebir P (2017) A growing disconnection from nature is evident in cultural products. Perspect Psychol Sci 12: 258–269.

Kjellgren A, Eriksson A, Norlander T (2009) Experiences of encounters with ayahuasca-“the vine of the soul”. J Psychoactive Drugs 41: 309–315.

Krebs T, Johansen P-Ø (2012) Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. J Psychopharmacol 26: 994–1002.

Krumpal I (2013) Determinants of social desirability bias in sensitive surveys: A literature review. Qual Quant 47: 2025–2047.

Kurzban R, Dukes A, Weeden J (2010) Sex, drugs and moral goals: Reproductive strategies and views about recreational drugs. Proc R Soc Lond B Biol Sci 277: 3501–3508.

Little TD, Cunningham WA, Shahar G, et al. (2002) To parcel or not to parcel: Exploring the question, weighing the merits. Struct Equ Modeling 9: 151–173.

Luke D (2011) Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology. J Soc Psych Res 75: 26–42.

Luna LE (1984) The healing practices of a Peruvian shaman. J Ethnopharmacol 11: 123–133.

Mabry EA, Khavari KA (1986) Attitude and personality correlates of hallucinogenic drug use. Int J Addict 21: 691–699.

MacLean KA, Johnson MW, Griffiths RR (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol 25: 1453–1461.

Maller C, Townsend M, Pryor A, et al. (2006) Healthy nature healthy people: ‘Contact with nature’ as an upstream health promotion intervention for populations. Health Promot 21: 44–54.

Masters R, Houston J (1966) The Varieties of Psychedelic Experience. New York, NY: Rinehart and Winston.

Mithoefer MC, Wagner MT, Mithoefer AT, et al. (2011) The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. J Psychopharmacol 25: 439–452.

Moffat BM, Johnson JL, Shoveller JA (2009) A gateway to nature: Teenagers’ narratives on smoking marijuana outdoors. J Environ Psychol 29: 86–94.

Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. J Psychoactive Drugs 18: 305–313.

Nichols DE (2004) Hallucinogens. Pharmacol Ther 101: 131–181.

Nisbet EK, Zelenski JM, Murphy SA (2009) The Nature Relatedness Scale: Linking individuals’ connection with nature to environmental concern and behavior. Environ Behav 41: 715–740.

Nutt DJ, King LA, Nichols DE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Rev Neurosci 14: 577–585.

Orians GH, Heerwagen JH (1992) Evolved responses to landscapes. In: Barkow JH, Cosmides L (eds) Adapted Mind: Evolutionary Psychology and the Generation of Culture. New York, NY: Oxford University Press, pp. 555–579.

Pai A, Heining M (2007) Ketamine. Contin Educ Anaesth Crit Care Pain 7: 59–63.

Paolacci G, Chandler J (2014) Inside the Turk: Understanding Mechanical Turk as a participant pool. Curr Dir Psychol Sci 23: 184–188.

R Core Team (2015) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.

Rand DG, Peysakhovich A, Kraft-Todd GT, et al. (2014) Social heuristics shape intuitive cooperation. Nat Commun 5: 3677.

Redmiles EM, Kross S, Pradhan A, et al. (2017) How Well Do My Results Generalize? Comparing Security and Privacy Survey Results from MTurk and Web Panels to the US. Retrieved from http://drum.lib.umd.edu/handle/1903/19164 (accessed 13 March 2017).

Rosseel Y (2012) Lavaan: An R package for structural equation modeling. J Stat Softw 48: 1–36.

Roszak TE, Gomes ME, Kanner AD (1995) Ecopsychology: Restoring the Earth Healing the Mind. Sierra Club Books. San Francisco, CA: Sierra Club Books.

Rudgley R (1995) The archaic use of hallucinogens in Europe: An archaeology of altered states. Addiction 90: 163–164.

Schultz PW, Stone WF (1994). Authoritarianism and attitudes toward the environment. Environ Behav 26: 25–37.

Sessa B, Johnson MW (2015) Can psychedelic compounds play a part in drug dependence therapy? Br J Psychiatry 206: 1–3.

Sessa B (2016) MDMA and PTSD treatment: “PTSD: From novel pathophysiology to innovative therapeutics”. Neurosci Lett 649: 176–180.

Shanon B (2002) The Antipodes of the Mind. New York: Oxford University Press.

Shapiro DN, Chandler J, Mueller PA (2013) Using Mechanical Turk to study clinical populations. Clin Psychol Sci 1: 213–220.

Shulgin A, Shulgin A (1991) PiHKAL. Berkeley, CA: Transform Press.

Smith C (1958) A new adjunct to the treatment of alcoholism: The hallucinogenic drugs. Q J Stud Alcohol 19: 406–417.

Speth J, Speth C, Kaelen M, et al. (2016) Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. J Psychopharmacol 30: 344–353.

Strassman R, Wojtowicz S, Luna LE, et al. (2008) Inner Paths to Outer Space: Journeys to Alien Worlds Through Psychedelics and Other Spiritual Technologies. Rochester, VT: Park Street Press.

Swendsen JD, Conway KP, Rounsaville BJ, et al. (2002) Are personality traits familial risk factors for substance use disorders? Results of a controlled family study. Am J Psychiatry 159: 1760–1766.

Tagliazucchi E, Roseman L, Kaelen M, et al. (2016) Increased global functional connectivity correlates with LSD-induced ego dissolution. Curr Biol 26: 1043–1050.

Tam KP, Lee SL, Chao MM (2013) Saving Mr. Nature: Anthropomorphism enhances connectedness to and protectiveness toward nature. J Exp Soc Psychol 49: 514–521.

Van Den Bosch MA, Depledge MH (2015) Healthy people with nature in mind. BMC Public Health 15: 1–7.

Vollenweider FX, Gamma A, Liechti M, et al. (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19: 241–251.

Vollenweider FX, Kometer M (2010) The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders. Nat Rev Neurosci 11: 642–651.

Waytz A, Cacioppo J, Epley N (2010) Who sees human? Perspect Psychol Sci 5: 219–232.

Whitmarsh L, O’Neill S (2010) Green identity, green living? The role of pro-Environmental self-identity in determining consistency across diverse pro-environmental behaviours. J Environ Psychol 30: 305–314.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.